Advertisement
Advertisement

CGON

CGON logo

CG Oncology, Inc. Common stock

54.92
USD
Sponsored
-1.75
-3.09%
Jun 10, 16:00 UTC -4
Closed
exchange

Pre-Market

55.54

+0.62
+1.13%

CGON Earnings Reports

Positive Surprise Ratio

CGON beat 4 of 10 last estimates.

40%

Next Report

Date of Next Report
Aug 06, 2026
Estimate for Q2 26 (Revenue/ EPS)
$340.91K
/
-$0.67
Implied change from Q1 26 (Revenue/ EPS)
-68.52%
/
-5.63%
Implied change from Q2 25 (Revenue/ EPS)
--
/
+24.07%

CG Oncology, Inc. Common stock earnings per share and revenue

On May 08, 2026, CGON reported earnings of -0.71 USD per share (EPS) for Q1 26, missing the estimate of -0.58 USD, resulting in a -20.40% surprise. Revenue reached 1.08 million, compared to an expected 311.61 thousand, with a 247.55% difference. The market reacted with a +0.64% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 12 analysts forecast an EPS of -0.67 USD, with revenue projected to reach 340.91 thousand USD, implying an decrease of -5.63% EPS, and decrease of -68.52% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Greenwich LifeSciences, Inc.
Report Date
Jun 04, 2026 For Q1 26
Estimate
-$0.33
Actual
-$0.39
Surprise
-15.86%
logo
Greenwich LifeSciences, Inc.
Report Date
Jun 01, 2026 For Q4 25
Estimate
-$0.32
Actual
-$0.57
Surprise
-77.70%
FAQ
For Q1 2026, CG Oncology, Inc. Common stock reported EPS of -$0.71, missing estimates by -20.4%, and revenue of $1.08M, 247.55% above expectations.
The stock price moved up 0.64%, changed from $69.18 before the earnings release to $69.62 the day after.
The next earning report is scheduled for Aug 06, 2026.
Based on 12 analysts, CG Oncology, Inc. Common stock is expected to report EPS of -$0.67 and revenue of $340.91K for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement